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Sullrlmal~r 
Interferon 7 (IFN-3') is a pleiotropic cytokine secreted by T lymphocytes and natural killer (NK) 
cells and has been noted to be a first line of host defense in the control of viral infections. To 
examine further the role of this cytokine in the control of viral infections, mice with a targeted 
mutation in the IFN-7 gene were infected with influenza virus, and the in vivo antibody and 
ceil-mediated immune response to viral infection were examined. In addition, cell lines and clones 
were derived from the immunized animals and the in vitro cytokine production and cytotoxic 
T lymphocyte (CTL) response were analyzed. The absence of IFN-3' led to increased production 
of influenza-specific IgG1, IL-4, and IL-5 as compared to wild-type littermate control animals. 
In contrast, there was no difference noted in the development of an effective CTL response between 
IFN-7-deficient and wild-type animals. In this model of experimental influenza infection, IFN-7 
is not necessary for the development of an effective humoral or cellular  immune response to 
challenge with this respiratory virus. 
I 
FN-% also known as immune or type II interferon, is a 
pleiotropic cytokine secreted by T  lymphocytes and NK 
cells. It has long been believed to be a first line of host de- 
fense in the control of viral infections.  Its effects are mul- 
tifaceted and include both direct and indirect activities. The 
direct antiviral activity attributed to IFN-% as well as to IFN-cr 
and IFN-B, includes the induction of proteins and enzymes 
that inhibit viral multiplication by impairing accumulation 
of viral-specific mRNA, double-stranded RNA, and proteins 
(1). In addition, dass I MHC-restricted CTL have been shown 
to secrete IFN-7 upon antigenic stimulation (2-4) and the 
differentiation of precursors to activated CTL has been reported 
to be dependent on the action of IFN-7 (5, 6). The indirect 
effects of IFN-7 include inhibition of cell growth and up- 
regulation of class I and II MHC molecules on APC, specifi- 
cally macrophages (7, 8). IFN-3' may also regulate antigen 
processing by augmenting the proteolysis and peptide trans- 
port machinery in APC (9,  10). 
The role of CTL in the host defense to influenza infection 
has been examined by a number of investigators (11-16). Both 
heterogeneous populations of immune spleen cells and cloned 
influenza-specific CTL have been shown to lyse vitally in- 
fected, MHC-matched target cells in vitro and to reduce lung 
virus titers and promote survival after adoptive transfer  to 
influenza virus-infected mice in vivo. The role of secreted 
cytokines by activated CTL, most notably IFN-% in the ob- 
served in vitro and in vivo antiviral effects has been unclear, 
and the relative importance of direct cytolysis versus soluble 
factors released by CTL has not been definitively determined. 
Although it has been suggested that CTL mediate their an- 
tiviral protective effects in vivo via direct cytolysis of virus- 
infected ceils (16), the potential role of soluble mediators 
released by the dones in high local concentrations could not 
be ruled out as playing a significant  role in recovery from 
influenza infection. The role that IFN-3, plays in clearance 
of influenza  virus mediated by CD4 + MHC  class II-re- 
stricted cytotoxic T cells is even less clear. In general, CD4 + 
cytotoxic T cells that have been shown to exhibit cytolytic 
effector functions in vitro and in vivo have belonged to the 
Thl subset of routine helper T cell dones (17, 18, and Graham, 
M. B., unpublished observations)  which secrete IFN-7 and 
IL-2 upon stimulation (19). These MHC class II-restricted 
CTL have been shown to promote virus dearance when adop- 
tively transferred  into influenza-infected animals. 
Recently, it has become possible to directly examine the 
role of cytokines in immune and inflammatory responses using 
gene disruption strategies (20-22).  In this report, we examine 
the in vivo cellular and humoral immune response to infec- 
tion with type A influenza virus in mice with a targeted mu- 
tation in the IFN-7 gene. In addition, the in vitro and in 
vivo antiviral effector activities  of virus-specific cytolytic T 
lymphocytes derived from these animals are compared with 
1725  j. Exp. Med. ￿9  The Rockefeller University Press ￿9  0022-1007/93/11/1725/08  $2.00 
Volume 178  November  1993  1725-1732 those of wild-type (WT) 1 littermates for antiviral activity 
in adoptive transfer. We show that IFN-3' is not necessary 
for either recovery from experimental influenza infection or 
for the in vivo effector activity of influenza-specific CD4 + 
or CD8 + cytotoxic T  cells which are cytolytic in vitro and 
protective in vivo. 
Materials and Methods 
Animals.  Male (8-9 wk of age) and female (6-7 wk of age) 
mice homozygous for a targeted disruption of the/FN-'y gene (IFN- 
3,o/o H_2  b) and WT littermates (IFN-3, '~t/wt, H-2  b) were derived 
as previously described (23). Murine pathogen-free male and fe- 
male C57B1/6 (H-2  b) 4-6-wk-old mice were purchased from Ta- 
conic Farms, Inc. (Germantown, NY) and used at 6-9 wk of age. 
Viruses.  Influenza virus  strain  A/JAP/57  (A/Japan/305/57 
[H2N2]) was  grown in the allantoic cavity of 10-d-old  embryo- 
nated hen eggs and stored as infectious allantoic fluid as previously 
described  (24). Determination of virus titer, expressed as hemag- 
glutinating units (HALl), was done as previously described (24). 
Pept/de.  The peptide corresponding to residues 366-379 of the 
influenza A/Japan/305/57  nucleoprotdn (NP 366-379)  was pro- 
duced manually by the rapid amino acid multiple peptide synthesizer 
system (DuPont Co., Wilmington, DE) and dissolved in DMSO 
(Sigma Chemical Co., St. Louis, MO) before final dilution in tissue 
culture medium. 
Cell  Lines.  The  EL-4  (H-2  b)  thymoma  was  maintained  in 
R.PMI (GIBCO BRL, Gaithersburg, MD) supplemented with 10%. 
(vol/vol) heat-inactivated  FCS  (HIFCS;  Hyclone Laboratories, 
Logan, UT), 1% glutamine (GIBCO BILL) and antibiotics (10 U/ml 
penicillin  G and 10/~g/ml streptomycin sulfate;  GIBCO BILL). 
The LB15.13 (H-2  TM) B cell hybridoma was maintained in high 
glucose DME,  10%  HIFCS,  1%  glutamine,  1%  nonessential 
amino acids, 0.5% sodium pyrnvate (all from GIBCO BILL), 5  x 
10 -s M 2-ME, and antibiotics. 
Immunization and Collection of  Serum.  Six 8-wbold female IFN- 
3  ,0/0 mice and six age-matched WT littermate female mice were 
bled via tail veins before immunization intraperitoneally with a 1:10 
dilution of A/JAP/57 allantoic fluid (5  x  102 HAU) in PBS. Mice 
were then bled on days 7, 14, 21, and 28 after immunization. Two 
mice from each group were killed on day 7 for analysis of in vivo 
primary cytolytic activity (see Results). The remaining four mice 
from each group were killed two at a time on days 21 and 28. 
Establishment and Maintenance of T Lymphocyte Bulk Cultures and 
Clones.  The  procedures  developed  to  establish  and  maintain 
influenza-specific bulk cultures clones are described in detail rise- 
where (25) with a few minor modifications. Briefly, spleen cells 
from immunized IFN-3, ~176  and IFN-3, w'/wt (described above) were 
harvested 1, 3, or 4 wk after immunization. In vitro secondary 
bulk cultures from individual mice were established by infecting 
one third of the autologous spleen cells with influenza A/JAP/57, 
combining these cells with the two-thirds uninfected splenocytes, 
and culturing the cells at a density of 5  x  10" cells per ml for 14 d 
in IMDM (GIBCO BILL), 10% FIIFCS, 1% glutamine, 5  x  10 -s 
M 2-ME, and antibiotics  (complete media). Subsequently,  the bulk 
cultures were stimulated in vitro with influenza A/JAP/57 virus- 
infected, "),-irradiated (2,000 tad) C57B1/6 spleen cells every 14 d 
with 10 U/ml human recombinant IL-2 (hulLlL-2; Biosource In- 
1  Abbreviations used in this paper: HALT, hemagglutinating unit; HIFCS, 
heat-inactivated FCS; huR.IL-2, human recombinant IL-2; NP, nucleo- 
protein; WT, wild type. 
ternational, Inc., Camarillo, CA) in complete media. Clones were 
derived by limiting dilution of viable cells from in vitro secondary 
bulk cultures. Clones were selected, expanded, and maintained in 
the presence of influenza A/JAP/57  virus-infected, 3,-irradiated 
C57B1/6 spleen cells in complete media with 10 U/ml huRIl~2. 
The clones were restimulated every 7 d in six-well cluster tissue 
culture plates (model 3506; Costar Corp., Cambridge, MA) con- 
taining  10S/ml  clone  cells,  5  x  10S/ml  infected,  irradiated 
C57B1/6 spleen cells, and 10 U/ml huRIL-2 in complete media. 
Cytokine Production.  Supernatants were collected from in vitro 
secondary bulk cultures 48 h after stimulation and frozen at -20~ 
Supernatants from clones were harvested 48 h after stimulation in 
the absence of huRIL-2 and frozen at -20~  Production of IFN-3, 
was assayed by ELISA as previously described (26) using Immulon 
96-well flat-bottom plates (Dynatech Laboratories,  Inc., Chantilly, 
VA). Production of IL-2, IL-4, and Ib5 was determined using routine 
cytokine immunoassay kits (Intertest-2X  mouse Ib2 ELISA kit from 
C-enzyme Corp., Cambridge, MA;  and routine I1.-4 ELISA and 
routine Ib5 ELISA kits from Endogen, Inc., Boston, MA). ELISA 
plates were read using an automated microplate reader (model EL 
340; Bio Tek Instruments,  Inc., Winooski, VT). 
Serum Ig Production.  ELISA plates were prepared by coating 
Immulon 96-well flat-bottom plates (Dynatech Laboratories,  Inc.) 
with 104 HAU influenza A/JAP/57 allantoic fluid in 100 #I PBS 
(pH 7.3) per well. Plates were covered and stored overnight at 4~ 
The plates were then washed three times with lx  ELISA wash 
buffer (0.02  M  NaHzPO4, 0.1  M  Na2HPO4,  1.5 M  NaC1,  and 
0.5% Tween 20, pH 7.4). Plates were blocked for 1 h with ELISA 
working and blocking buffer (2% BSA and 0.1% Tween 20 in lx 
PBS, pH 7.3). Plates were washed three times, and serial dilutions 
of sera from each animal (diluted in working buffer) were added 
to the plate and incubated for 2 h  at 37~  Plates were washed 
three times, a 1:1,000 dilution of alkaline phosphatase-conjugated 
goat anti-mouse  IgG1  or IgG2a  (Southern Biotechnology As- 
sociates, Birmingham, AL) was added to each well, and plates were 
incubated for 2 h at 37~  The plates  were washed a final three 
times, 1 mg/ml p-nitrophenyl phosphate disodium (Sigma Chem- 
ical  Co.)  in  substrate buffer (1  M  diethanolamine,  0.1  mg/ml 
MgC12, and 0.2%  NAN3)  was added to each well,  and a color 
change was allowed  to develop for 1 h. OD read at 415 nm on 
an ELISA microplate reader (Bio Tek Instruments,  Inc.). 
Assays for Cell-mediated Cytotoxicity.  The SlCr-release cytotox- 
icity assay was carried out as previously described (24). Briefly, 10' 
target cells, either EL-4 or LB15.13, were either left uninfected, 
infected with influenza A/JAP/57, or pulsed with 1.0 t~g/ml NP 
366-379  in the presence of SlCr for 1.5 h at 37~  Targets were 
then washed three times and plated at 5  x  103 cells per well in 
96-well, flat-bottom, microtiter tissue culture plates in 0.1-ml vol 
of RPMI plus 10% HIFCS. Effector cells were added in a 0.1-ml 
vol of RPMI plus 10% HIFCS to appropriate wells in quadrupli- 
cate. E/T ratios ranged from 5:1 to 100:1, depending on the assay. 
The plates  were incubated at 37~  in 10% CO2 for 3 h. From 
each well, 0.1 ml of supernatant was removed and counted on a 
gamma counter (Isomedic; ICN Biomedicals,  Inc., Costa Mesa, 
CA). The percent specific lysis was determined as previously de- 
scribed  (16). SEM were always <5%  of the mean value and are 
omitted. 
Intranasal Influenza  Virus Inoculation.  Intranasal inoculation of 
mice was performed as previously described (16). The procedure 
was modified from that described by using light anesthesia  from 
methoxyflurane (Pitman-Moore,  Mundelein,  IL). To evaluate  a 
dose-response to intranasal virus, animals  received serial 10-fold 
dilutions of allantoic fluid in cold PBS ranging from 10 .2 to 10 -6, 
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LDs0 values  were  calculated  according  to a modified  Spearman  and 
Karber method (27). 
Adaptive Transfer  Procedure.  Adoptive transfer of day 6 viable 
cloned cells was performed  as previously  described  (16). 9-wk-old 
male C57B1/6 mice were intranasally inoculated with 10 LDs0 
influenza A/JAP/57 virus and within 30 min, 107 clone cells in 
0.5 ml IMDM (GIBCO BRL) were injected  intravenously.  Con- 
trol mice were  injected intravenously  with 0.5 ml IMDM alone. 
Mice were watched  daily for 21 d for morbidity and/or mortality. 
Results 
Ability of  lFN-7-deficient Mice and WT Littermates to Generate 
a Cytotoxic T Cell Response to Challenge with Influenza.  To 
evaluate the rule of IFN-'y in the routine host response to 
infectious  influenza virus,  we immunized H-2  b haplotype 
mice generated with a targeted mutation in the IFN-q( gene, 
and with no demonstrable IFN-'y production, and their WT 
littermates.  Six female mice homozygous for the mutation 
in the IFN-'), gene, designated IFN-q( deficient, and six WT 
female littermates were initially analyzed for the ability to 
mount a  CTL  response  to  immunization with influenza 
A/JAP/57 virus. In vitro secondary bulk cultures of immune 
splenocytes from both IFN-'u deficient and WT animals were 
able to lyse vitally infected targets with similar efficiencies 
(Fig. 1). In addition, MHC dass II-negative, H-2Db-expres  - 
sing EL4 ceUs treated with a synthetic peptide corresponding 
to type common influenza NP were also recognized equally 
well by IFN-~, deficient and WT bulk cultures. This peptide 
(amino acid 366-379) mimics an immunodominant epitope 
on the NP recognized by class I MHC-restricted T lympho- 
cytes from H-2  b haplotype mice in association with H-2D  b 
(28). Analysis of in vivo primary CTL responses by standard 
chromium release assay  did not reveal  demonstrable influenza- 
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Figure  1.  Recognition of target cells by in vitro secondary bulk spleno- 
cyte  cultures  derived  from IFN-'),-defident (IFN-',/o/o) and  wild-type 
(IFN-3,  *'/~) littermate  mice. Secondary bulk cultures derived from IFN- 
3,  ~  mice (open columns)  or from IFN-')  ,*tA*t mice (hatched  columns)  were 
tested  for  reactivity on  mock  (uninfected), A/JAPAN/57-infected,  or 
NP3~s-3y9 peptide--treated  (1  #g/ml)  EL-4 target  cells. E/T ratios  are 
shown under each column. SEM depicted by error bars. Spontaneous  re- 
lease from mock- and peptide-treated  Eb4 cells was <15%. Spontaneous 
release from A/JAPAN/57-infected  ED4 cells was <20%. 
specific CTL from either IFN-3' deficient or WT littermates 
(data not shown). 
Cytokine Production by In Vitro Secondary Bulk Cultures  from 
IFN-T Deficient and WT Mice.  To ensure that splenocytes 
from immunized IFN-q/-deficient mice did not produce any 
measurable IFN-3,, supernatants from in vitro secondary bulk 
cultures were analyzed for the production of IFN-'),. As ex- 
pected, IFN-y-deficient bulk cultures released no detectable 
IFN-% whereas bulk cultures from WT animals produced 
variable amounts of IFN-'y (Table 1). The same supernatants 
were then analyzed for the production of IL-2, IL-4, and IL-5 
(Table 1). In the absence of IFN-% the production of IL-4 
and IL-5 was significantly higher than that in WT bulk cul- 
tures. There was no statistical difference in the amounts of 
IL-2 produced by the IFN-'),-deficient bulk cultures versus 
those from WT animals. Subsequent stimulation of  bulk cul- 
tures with irradiated,  virus-infected splenocytes from WT 
mice yielded identical results (data not shown). Stimulation 
of IFN-~/-defieient cultures with irradiated, infected spleno- 
cytes from normal mice that have an intact IFN-3' gene, did 
not alter the cytokine production profile of the cultures. 
Humoral Immune Response to Immunization with Influenza 
Virus in IFN-7-deficient  and  WT Mice.  IFN-3,  has been 
reported to be crucial in antibody class switch during the 
maturation of a humoral immune response (29, 30). To assess 
the impact  of IFN-3, in determining the humoral immune 
response of the animals to immunization with influenza, mice 
were inoculated parenterally with influenza virus, and sera 
from serial bleeds of the immunized animals was assayed  for 
influenza-specific IgG1 and IgG2a antibodies  (Table 2).  In 
mice lacking IFN-'),, the IgG1 antibody response to type A 
influenza was significantly higher than the response of the 
WT animals. This finding is in agreement with previous 
studies (29) that have shown that IFN-3' blocks the ability 
of B cells to respond to IL-4, thereby decreasing synthesis 
of IgG1 and IgE. Thus, in the absence of IFN-3, and an in- 
creased production of IL-4 (Table 1), antibody dass switch 
Table  1.  Cytokine Production by In  Vitro Secondary Bulk 
Splenocyte Cultures Derived  from IFN.~,-cleficient (IFN.~/o/~ 
and Wild Type (IFN-'y  wr/*t) Littermate Mice 
Cytokine produced  IFN-3,  ~176  IFN-3,  *,/w, 
IFN-3' (U/ml)*  None detectable  154.8 (72.3)*s 
IL-2 (pg/ml)  408.3 (279.4)  150.0 (75) 
IL-4 (pg/ml)  342.2 (64.8)s  66.8 (31.1) 
IL-5 (pg/ml)  1,846.7 (611.6)s  605 (140.75) 
* 48-h culture supernatants  from in vitro secondary bulk splenocyte cul- 
tures were assayed on at least two separate occasions for cytokine produc- 
tion by ELISA. 
* Values  equal  the average  amount  of each cytokine produced  by six 
separate IFN-3~  o/o bulk cultures and six separate IFNw  ,~/~ bulk cultures. 
SEM for each  set of data  are  shown in parentheses. 
S Data represent  significantly  higher levels of cytokine produced. 
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Deficient and  WT Littermate Mice 
Ab production  IFN-'y-deficient 
(OD~ls)  Serum dilution  WT group  group 
IgGl*  1:100t  0.51 (0.14)s  0.99 (0.13) 
1:200  0.42 (0.08)  0.96 (0.10) 
1:400  0.38 (0.06)  0.87 (0.08) 
1:800  0.33 (0.04)  0.70 (0.08) 
1:1600  0.25 (0.03)  0.50 (0.06) 
1:3200  0.16 (0.02)  0.30 (0.04) 
IgG2a  1:100  1.51 (0.22)s  1.08 (0.19) 
1:200  1.45 (0.20)  1.01 (0.21) 
1:400  1.30 (0.17)  0.86 (0.20) 
1:800  1.10 (0.15)  0.69 (0.17) 
1:1600  0.82 (o.11)  0.50 (0.14) 
1:3200  0.54 (0.07)  0.33 (0.09) 
* P-value for comparison of the two groups for IgG1 production: 0.005. 
P-value for comparison  of the two groups for IgG2a production: 0.14. 
t All sera coUected on day 14 after immunization. 
S Values represent the mean OD of four animals from each group with 
SEM in parentheses. 
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to IgG1 is favored. Although the production of IgG2a was 
slightly diminished in the IFN-'y-deficient animals, the level 
was not significantly lower than the amount made by the 
WT animals. This result is in keeping with previous in vitro 
studies which examined the effect of neutralizing anti-IFN-y 
antibody on isotype switch during humoral immune  responses 
(31). Analysis  of preimmune serum samples from these animals 
revealed  no detectable  levels of  influenza-specific  IgG1 or IgG2a 
(data not shown). 
Evaluation of  In Vitro and In Vivo Effector Function of Clones 
from IFN-7-deficient and WT Animals.  To investigate fur- 
ther the role of IFN-3' in determining in vitro and in vivo 
function of T cells derived from immunized IFN-3: deficient 
and WT animals, T cell clones were derived by limiting di- 
lution from in vitro secondary bulk cultures (see Materials 
and Methods). A total  of 38 clones from IFN-~/-deficient 
WT animals were analyzed for cytolytic potential,  antigen 
specificity, and MHC restriction.  Five representative clones 
were chosen for further in vitro and in vivo analyses, one 
CD4 + MHC dass II restricted and two CD8 + MHC class 
I restricted  clones from the IFN-'y-deficient bulk cultures 
and two CD8 + MHC class I restricted clones from the WT 
bulks were selected on the basis of their ability to lyse vitally 
infected H-2  b MHC dass I or II expressing target cells. IFN- 
"y-deficient clones  G-11D6  and G-11E4, and WT  clones 
W-16G8 and B1.11 express CD8 as assessed by flow cytom- 
etry (data not shown) and lyse vitally infected EL-4 cells and 
EL-4 cells treated with the Db-restricted NP3~6-379 peptide 
(Fig. 2). EL-4 cells express only dass I MHC molecules of 
Figure 2.  Recognition of target cells by clones derived from IFN-y- 
defident and WT littermate mice. (a) Eb4 or (b) LB15.13 target cells were 
slCr labeled and either  left  uninfected,  treated  with NP 366-379  (1 
#g/ml), or infected with A/JAPAN/57. Clones B1.11 (,), W-16G8 (Q), 
G-11D6 (~), G-11E4 (~), and G-4D7 (~) were added for a final E/T 
ratio of 5:1. Spontaneous release for all target  cells was <15%. Data is 
representative of multiple assays performed with these cells. 
the H-2  b haplotype.  The IFN-'y deficient done G-4D7 ex- 
presses CD4 as assessed  by flow cytometry  (data not shown). 
This T lymphocyte clone was unable to lyse viraUy infected 
or peptide-treated EL-4 targets, but did lyse vitally infected 
LB15.13 target cells which express both MHC class I and 
II for H-2  b haplotype (Fig. 2). All of these clones have been 
stable in culture for more than 6 mo. None of the clones 
from IFN-'y-deficient mice secreted measurable levels of IFN 
% whereas clones W-16G8 and B1.11 produced 64 U/ml and 
72  U/ml  IFN-7  upon  stimulation,  respectively.  Clones 
G-11E4, G-11D6, W-16G8, and B1.11 had no detectable levels 
of IL-2, IL-4, or IL-5, whereas the CD4 + IFN-3,-deficient 
clone G-4D7 secreted measurable levels of IL-2,  IL-4, and 
IL-5 (159, 59,  and 960 pg/ml, respectively). 
Our laboratory has previously  examined the ability of  cloned 
CTL to promote recovery after transfer into lethally infected 
animals by adoptive transfer experiments (16). To assess the 
function of CTL dones lacking  a functional IFN-'y gene, 
cloned T cells from the mutant and WT mice were adop- 
tively transferred into histocompatible  C57B1/6 mice chal- 
lenged with a lethal intranasal inoculation of influenza (Fig. 
3). The three IFN-'y-deficient clones G-4D7, G-11D6, and 
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Figure  3.  Adoptive  transfer of  donas derived  from IFN-3'-deficient  and 
WT littermate mice into lethally challenged C57Bi/6 mice. Within 30 
min of intranasal inoculation of  a lethal dose  of  A/JAPAN/57 into C57B1/6 
mice, 107 done cells (day 6 after stimuhtion) were injected intravenously. 
Mice were observed  for 21 d for morbidity and mortality. Clones G-4D7 
(0), G-11D6 (A), G-11E4 (A), and B1.11 (O) were injected into groups 
of six animals each. Clone W-16G8 (D) was injected into three animals, 
and 14 control animals (m) received no done. 
G-11E4,  and the WT clone B1.11 each promoted recovery 
from lethal  viral challenge  with  influenza  A/JAP/57.  Al- 
though  IFN-3' has  been noted to have potent antiviral  ac- 
tivity, and has been suggested to play a critical role in the 
function of virus-specific CTL (2, 4), production of IFN-3, 
by either CD4 + or CD8 + cytotoxic T  cells is not required 
for expression of antiviral effector activity in vivo. WT clone 
W-16G8 did not demonstrate  any in vivo protective capa- 
bility despite its ability to lyse virally infected target cells and 
produce IFN-3' in vitro. The defect in clone W-16G8 is cur- 
rently being evaluated. 
In Vivo  Response to Influenza Infection in IFN-  y-deficient and 
WT  Mice.  Since  either  CD4 +  or  CD8 +  IFN-3,-defi- 
cient T  lymphocyte clones promoted recovery from lethal 
influenza infection upon adoptive transfer,  we next examined 
the response of IFN-3,-deficient mice to pulmonary  infec- 
tion with influenza virus. To assess the impact of IFN-'y ex- 
pression on susceptibility to infection with influenza virus, 
WT and IFN-3/-deficient mice were inoculated intranasally 
with varying doses of infectious mouse-adapted influenza virus. 
Although at the highest doses of virus given, the WT animals 
died in a slightly faster time frame (ranging from 24 to 48 h) 
during the first 7 d after infection, both the time to death 
and minimal lethal dose of virus were identical for both the 
IFN-'y-deficient  and WT  animals  (Fig.  4). 
Discussion 
IFN-3, is a pleiotropic cytokine with  wide-ranging  im- 
munomodulatory  effector functions.  In  this  model  of ex- 
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Figure 4.  In vivo response to influenza infection in IFNw--deficient 
and WT littermate mice. Groups of four 9-11-wk-old IFN-T-ddicient 
(O) and WT littermate (A) mice were  intranasally inoculated with varying 
concentrations of mouse-adapted  A/JAPAN/57  influenza virus diluted in 
PBS. Mice were observed for 21 d for morbidity and mortality. 
perimental influenza infection, its absence did lead to differen- 
tial antibody response and cytokine production as compared 
with controls, but did not affect the development of an effec- 
tive ceU-mediated immune  response to a respiratory virus. 
The role that IFN-'), plays in differentiation of precursors into 
CTL, thereby influencing the cell-mediated immune response, 
has been controversial. Originally it was thought that IFN-3, 
was an essential cofactor in these precursors and was neces- 
sary for CD8 + T  cells  to acquire cytolytic activity (5,  6). 
Other studies have indicated that IFN-'y is not necessary for 
the induction  of CTL in MLC and that  IL-2 is the prime 
cytokine needed for growth and differentiation of CTL (32, 
33). Additional lines of investigation have also implicated IL-4 
as a prime inducer of CTL (34, 35). In the bulk cultures gener- 
ated from IFN-3~-deficient mice, variable amounts of both 
IL-2 and IL-4 were produced, thus potentially playing a signi- 
ficant role in the generation of cytotoxic T cells in these popu- 
lations in the absence of IFN-% 
The results of the adoptive transfer experiment are consis- 
tent with speculations made previously by our laboratory that 
in experimental influenza infection, direct cytolysis of vitally 
infected cells may be the primary mechanism by which clonal 
populations of CD8 + CTL express their antiviral effector ac- 
tivity in vivo (16). Similarly, IFN-'y deficiency did not have 
a significant  impact on recovery from infection in this ex- 
perimental  model for influenza infection.  As shown previ- 
ously, IFN-3,-deficient mice are unable to control infection 
with  the intracellular  mycobacterium, Mycobacterium boris 
(BCG strain) (23). Also, IFN-'y receptor-deficient mice have 
been shown to be unable to control infection with the intra- 
cellular bacterium, Listeria monocTtogenes  (36). Furthermore, 
in experimental vaccinia virus infection, vaccinia virus is le- 
1729  Graham  et al. thai in IFN-~/receptor-deficient mice, suggesting that in this 
viral infection, IFN-3, may play a critical modulating role 
(36). It seems likely, therefore, that the importance of IFN-~/ 
in clearance of a pathogen and recovery will vary among 
microorganisms. 
Previous studies (17) from this laboratory have demonstrated 
that influenza-specific CD4 + T  lymphocytes can eliminate 
infectious virus and promote recovery from lethal experimental 
infection when CD4 + T  cell clones are adoptively trans- 
ferred in vivo. An interesting feature of these early studies 
was the finding that protective CD4 + T cell populations ex- 
press  specific cytolytic activity similar to influenza-specific 
CD8 + T lymphocytes. In addition, these protective CD4 + 
T lymphocyte populations secrete a constellation of cytokines 
upon antigenic stimulation, including IL-2 and IFN-% and 
fall into the subset ofThl T cells. In the present report, clone 
G-4D7, derived from an IFN-y-deficient animal, was able 
to lyse virally infected MHC class II expressing targets in 
vitro and promote recovery from lethal viral challenge in vivo. 
The mechanisms by which CD4 + T  cells may be involved 
in promoting recovery from viral infection include both hu- 
moral and cellular immune responses. It is well established 
that in experimental influenza infection, CD4 + T  cells can 
support antigen-specific B cell responses with production of 
influenza-specific antibodies (37). The mechanism(s) by which 
clone G-4D7 acts could include specific antibody production 
as a result orb cell help and cytokine production, in addition 
to direct cytolytic effector activity on viraUy infected respira- 
tory epithelial cells. In this model, IFN-3, does not appear 
to be necessary for either the in vitro or in vivo effector func- 
tion of CD4 + , influenza-specific,  cytolytic clones. 
In this study, there was no significant difference in the 
amounts of influenza-specific IgG2a antibody made by the 
IFN-qr-deficient or WT animals.  IFN-y has potent effects 
on B cells, stimulating B cell proliferation and active Ig secre- 
tion and isotype switch from IgM to IgG2a (29). IgG2a syn- 
thesis may be promoted by other cytokines, such as IL-2, 
since it has been shown that although IFN-3' produced by 
Thl cells promotes IgG2a synthesis, neutralization of IFN-y 
by the addition of anti-IFN-3, antibody does not affect the 
IgG2a  antibody production  promoted by cytokines from 
CD4 + Thl  T  cells (31).  In immune responses to viral in- 
fections with both RNA and DNA viruses, IgG2a is the dom- 
inant antibody response, followed by IgG1 (38).  The IgG2a 
response to viral infection has been speculated to be advanta- 
geous because of its ability to fix complement and bind Fc 
receptors on both macrophages and NK cells, potentially en- 
hancing the ability to combat intracellular infections (30). 
In these experiments, the viral-specific IgG1 antibody response 
was significantly higher in the IFN-~/-deficient versus  the 
WT animal, presumably reflecting increased production of 
IL-4 in the absence of IFN-~/and therefore a greater switch 
to IgG1 production (20). 
These observations differ from those made in mice lacking 
the IFN-3, receptor (36), where there was no demonstrable 
difference in IgG1 antibody response to immunization with 
OVA, but a reduced IgG2a antibody response in the mutant 
animals. An intriguing explanation for this difference is that 
IFN-3' receptor-defident mice still produce IFN-% and poten- 
tially a second receptor for IFN-3' exists, such as was discov- 
ered for IL-1  (39).  Alternatively, studies have shown that 
different cytokines can cross-compete for the same receptor 
(40) and may account for the lack of a difference in IgG2a 
production in our experimental model. 
In conclusion, we have shown that animals lacking en- 
dogenous production of IFN-3~ do not differ significantly from 
mice  that  make  IFN-'y  normally  when  challenged with 
influenza virus. Although deficient in IFN-% these animals 
express functional IFN-ol and IFN-~. Activities of these potent 
antiviral effectors could potentially account for the lack of 
differences observed. In addition, cloned CD4 + and CD8 § 
influenza-specific T cells do not require IFN-y to lyse vitally 
infected target cells in vitro or to clear influenza infection 
in vivo. The availability of cloned CTL from IFN-'y-deficient 
mice with in vitro and in vivo functional activities will en- 
able us to study further the role different cytokines play in 
determining these effector mechanisms. 
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